Navigation Links
MINRAD International, Inc. to Discuss Current Business Conditions on Tuesday, November 25, 2008
Date:11/19/2008

ORCHARD PARK, N.Y., Nov. 19 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (Amex: BUF), announced today the Company will hold an investor conference call to discuss current business conditions on Tuesday, November 25, 2008 at 11:00 am ET. The toll free call in number is (866) 901-2585. The international call in number is (404) 835-7099.

     Contact:  Charles R. Trego, Jr., Executive Vice President
               & Chief Financial Officer
               ctrego@minrad.com
               (716) 855-1068
              http://www.minrad.com

About the Company

The Company is an interventional pain management company with three focus areas: (1) anesthesia and analgesia, (2) real-time image guidance, and (3) conscious sedation. The Company's products are sold throughout the world. The anesthesia and analgesia business currently manufactures and sells generic inhalation anesthetics that are used for human and veterinary surgical procedures. The Company manufactures patented real-time image guidance technologies that facilitate minimally invasive surgery. The SabreSource(TM) system and the accompanying Light Sabre(TM) disposable products have broad applications in orthopedics, neurosurgery, interventional radiology and anesthesia. They enable improved accuracy and reduced radiation in interventional procedures and support the transfer of these procedures to the outpatient setting. The Company is in the process of developing a drug /drug delivery system for the use of halogenated ethers as inhalation analgesics for conscious sedation.


'/>"/>
SOURCE MINRAD International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
2. MINRAD International, Inc. Announces the Start of the MINRAD International Distributor Meeting in Cape Town, South Africa
3. MINRAD International, Inc. to Discuss 2007 Fourth Quarter and Full Year Financial Results on Monday, March 31, 2008
4. MINRAD International, Inc. Announces 2007 Financial Results
5. MINRAD International, Inc. Announces FDA Approval of Petrem(TM) Sevoflurane
6. MINRAD International, Inc. to Discuss 2008 Second Quarter Financial Results on Thursday, August 14, 2008
7. MINRAD International, Inc. Announces Change in Distribution Agreement with RxElite Holdings, Inc.
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
10. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
11. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...ortunity for you to change your life - After just ...ll experience a noticeable relief from the terribl...ol levels and blood pressure will return to normal... finally be freed from the health concerns that ac... Miami, FL (PRWEB) July 3, 2...
(Date:7/2/2009)...nology Institute (BTI) have made a novel discovery...ecule" (FAIM), protects both immune and liver cell...heir research is published in the current journal ...ts, Jianxin Huo, Ph.D., and Shengli Xu, Ph.D., als...ipulated for clinical application and proposed the...
(Date:7/2/2009)... Pro-life forces won an important battle yesterday...te law regulating that abortion centers must prope...(also known as the "abortion pill") in order to pr...The ruling came in Rogers v. Planned Parenthood ,...equiring that those administering RU-486 comply wi...
(Date:7/2/2009)..., expert says , , THURSDAY, July 2 (Heal... species of wildlife, which need to be protected t...ancer is one of the leading health concerns for hu... deaths. But we now understand that cancer can kil...se McAloose, chief pathologist for the Wildlife Co...
Breaking Medicine News(10 mins):Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 2Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 3Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 4Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2Health News:Cancer Endangers Some Wildlife Species 2
...cer is the fifth major cause of death among women,... needed, according to the // latest recommendation...ancer screening for women saying the harms outweig...y there is no existing evidence that any screening...
... say , that the drug aspirin ,best known for its p...protection against breast cancer. // Cancer preven...style factors, but recent research has been center...mical agents to prevent or inhibit the carcinogeni...
...he heart is one of the most worrisome long-term si...sts. Hence they feel the // need to identify bioch...are at greatest risk and how severe their heart di... present only in heart cells. TNI blood concentrat...
...rcent of people over 65 years old have diabetes. A...k for Alzheimer’s disease.// The Study included 8...llowed for more than five years. All of them under...ing cognitive testing. Researchers looked at five ...
Other Medicine News:
(Date:6/30/2009)...0 Calixa Therapeutics Inc. today a...l of CXA-101 in patients with complicated urinary ..., parenteral cephalosporin antibiotic with excelle...domonas aeruginosa , including drug resistant isol...ial treatment for serious bacterial infections in ...
(Date:6/29/2009)... Seeks to Assess RSV Burden in Outpatient Setting ...to Pediatric Research , , GAITHERSBURG, Md., ...ance its commitment to pediatric research with tod...ective study designed to assess the burden of resp...s 32-to-35 weeks gestational age (GA) in outpatien...
(Date:6/29/2009)...dominal surgery patients achieved primary and seco...29 AcelRx Pharmaceuticals, Inc. to...se 2 clinical study evaluating the safety and effi... management of acute post-operative pain in patien...on. Compared to placebo, patients receiving ARX-01...
(Date:6/29/2009)...England, June 29 Vantia Therapeuti... novel, small molecule drugs,targeting large, und...ts from,a Phase IIa clinical trial of its lead de...al showed that oral VA106483 was successful in pro...effect in patients, as determined by,increased os...
Breaking Medicine Technology:Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Impact of floods on soils 7909 1Impact of floods on soils 7909 2Heartburn Sufferers Find Lasting Relief With TUMS 28R 29 Dual Action 42045 1Heartburn Sufferers Find Lasting Relief With TUMS 28R 29 Dual Action 42045 2Heartburn Sufferers Find Lasting Relief With TUMS 28R 29 Dual Action 42045 3Autism Software Developer Announces Hiring of Susan DuRant as Director of Education 42042 1Autism Software Developer Announces Hiring of Susan DuRant as Director of Education 42042 2AAID Hails Florida Court Verdict Allowing Advertising of Bona Fide Dental Credentials 42038 1AAID Hails Florida Court Verdict Allowing Advertising of Bona Fide Dental Credentials 42038 2
... 6, 2007 - ZIOPHARM Oncology, Inc.,(NASDAQ: ZIOP) ...cutive Officer, will present at the C.E. Unterberg...on Thursday, July 12, 2007,at 2:30 p.m. ET at the ...provide an overview of the Company and an update o...tion will be webcast live and can be accessed by,v...
...IRE)--Jul 5, 2007 - GTC,Biotherapeutics, Inc. ("GT...x, Ph.D., GTC,s Chairman and CEO, is scheduled to,...uring the C.E.,Unterberg, Towbin Emerging Growth L...ing held at the Mandarin Oriental Hotel, New,York,...on will be webcast live and can be accessed by,log...
Other Medicine Technology:ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2GTC Biotherapeutics to Webcast Corporate Presentation at the C.E.,Unterberg, Towbin Emerging Growth Life Opportunities Conference 2
Narrow smooth jaws. Serrated handle with polished finish.
14 mm oval solid lower plate and straight 9 mm serrated upper jaw. Locking thumb screw and serrated handle with polished finish.
Round solid 10 mm wide lower plate. Open upper plate with inside diameter 8 mm. Serrated handle with locking thumb screw and polished finish. Most popular size or model.
Utrata-like fine angled tips with gently curved shaft for performing capsulorhexis through tunnel incisions. Dull finish. Flat handle.
Medicine Products: